CHRISTIE BEHRENS: Open Payments
NPI 1518327469 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 24 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,033
Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 6 | $237 |
| Amgen Inc. | 4 | $180 |
| Mallinckrodt Hospital Products Inc. | 2 | $144 |
| ABBVIE INC. | 6 | $137 |
| Janssen Scientific Affairs, LLC | 2 | $130 |
| AstraZeneca Pharmaceuticals LP | 1 | $81 |
| Novartis Pharmaceuticals Corporation | 1 | $73 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| KYOWA KIRIN, INC. | 1 | $25 |
Products named: Bimzelx, ACTHAR, TREMFYA, RINVOQ, SAPHNELO, SKYRIZI, EVENITY, Sotyktu.
Industry payments across TX — which companies pay providers there.
